» Articles » PMID: 35693944

Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation

Overview
Specialty Cell Biology
Date 2022 Jun 13
PMID 35693944
Authors
Affiliations
Soon will be listed here.
Abstract

Deregulation of cellular metabolism through metabolic rewiring and translational reprogramming are considered hallmark traits of tumor development and malignant progression. The transcription factor YY1 is a master regulator of metabolism that we have previously shown to orchestrate a metabolic program required for melanoma formation. In this study, we demonstrate that YY1, while being essential for primary melanoma formation, suppresses metastatic spreading. Its downregulation or loss resulted in the induction of an invasiveness gene program and sensitized melanoma cells for pro-invasive signaling molecules, such as TGF-β. In addition, NGFR, a key effector in melanoma invasion and phenotype switching, was among the most upregulated genes after YY1 knockdown. High levels of NGFR were also associated with other metabolic stress inducers, further indicating that YY1 knockdown mimics a metabolic stress program associated with an increased invasion potential in melanoma. Accordingly, while counteracting tumor growth, loss of YY1 strongly promoted melanoma cell invasiveness and metastasis formation in melanoma mouse models . Thus, our findings show that the metabolic regulator YY1 controls phenotype switching in melanoma.

Citing Articles

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment.

Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L Front Oncol. 2023; 13:1122110.

PMID: 37081988 PMC: 10110844. DOI: 10.3389/fonc.2023.1122110.


Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma.

Lehmann J, Caduff N, Krzywinska E, Stierli S, Salas-Bastos A, Loos B Sci Adv. 2023; 9(2):eadc8825.

PMID: 36638181 PMC: 9839334. DOI: 10.1126/sciadv.adc8825.


New Insights into the Phenotype Switching of Melanoma.

Pagliuca C, Di Leo L, De Zio D Cancers (Basel). 2022; 14(24).

PMID: 36551603 PMC: 9776915. DOI: 10.3390/cancers14246118.

References
1.
Jiang L, Xiao L, Sugiura H, Huang X, Ali A, Kuro-o M . Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition. Oncogene. 2014; 34(30):3908-16. PMC: 4387121. DOI: 10.1038/onc.2014.321. View

2.
Goding C . Commentary. A picture of Mitf in melanoma immortality. Oncogene. 2011; 30(20):2304-6. DOI: 10.1038/onc.2010.641. View

3.
Varum S, Baggiolini A, Zurkirchen L, Atak Z, Cantu C, Marzorati E . Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation. Cell Stem Cell. 2019; 24(4):637-653.e9. DOI: 10.1016/j.stem.2019.03.011. View

4.
Fang Z, Yang H, Chen D, Shi X, Wang Q, Gong C . YY1 promotes colorectal cancer proliferation through the /E2F1 axis. Am J Cancer Res. 2020; 9(12):2679-2692. PMC: 6943347. View

5.
Gao P, Li L, Yang L, Gui D, Zhang J, Han J . Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFβ1. Sci Transl Med. 2019; 11(510). DOI: 10.1126/scitranslmed.aaw2050. View